Netherlands: Researchers have found in a new study that stratifying mean arterial pressure (MAP) goals by hypotension risk ...
7don MSN
Why blood pressure falls when you stand up: Understanding the causes, symptoms, risks and management
Experiencing dizziness upon standing, known as orthostatic hypotension, signals a temporary blood pressure drop. This occurs ...
Heart failure is a complex clinical syndrome affecting around 70 million individuals globally. It has a prevalence of 2% in ...
Sportschosun on MSN
49kg possession, diet too much? Dizziness and establishment hypotension get worse
Singer Soyou, who lost up to 49kg, confessed his diet side effects.On the 27th, Soyou's YouTube channel posted 'My weight is.. A video titled 'Shocked Soyou | Tips for Retaining After Dieting' was ...
Onlymyhealth on MSN
World Movement Disorders Day 2025: How Lifestyle Changes Can Slow The Progression Of Parkinson's
Did you know that with the help of healthy lifestyle choices you can slow down the progression of Parkinson’s disease Our ...
Introduction Post-induction hypotension (PIH) is a critical concern in elderly surgical patients and is associated with adverse postoperative outcomes. This trial aims to compare the effects of ...
Low blood pressure—also known as hypotension—is a serious condition that can affect the blood flow and oxygen to your organs. While normal blood pressure is 120/80 mmHg, low blood pressure is usually ...
Doctors at Care Hospitals, Malakpet, successfully performed a high-risk laparoscopic gallbladder surgery on a 72-year-old ...
13don MSN
Top Cardiologist reveals how your arm position can affect Blood Pressure while measuring it
According to Dr Levine, proper arm placement is needed for the right blood pressure reading. The American Heart Association, ...
New research contributes valuable data that may help low-dose ketamine infusions become more widely accepted as a safe and ...
Most patients taking GLP-1 agonists are experiencing positive outcomes for managing type 2 diabetes and obesity. With all the ...
Stockhead on MSN
Alterity delivers encouraging phase II data in MSA trial
Alterity Therapeutics’ phase II study of its lead compound ATH434 in multiple system atrophy (MSA) has been featured in an oral presentation at the American Autonomic Society (AAS) 36th International ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results